COMP vs MRNA · rev $5.63B vs rev $1.94B
Compass Inc (COMP) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Compass Inc (COMP) is a real estate services company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
COMP currently screens at market cap $3.35B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the COMP and MRNA stock pages for the full models.
Not investment advice.